Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2022

01-04-2022 | Coronavirus | IM - ORIGINAL

Comparison of characteristics and outcomes of patients admitted to hospital with COVID-19 during wave 1 and wave 2 of the current pandemic

Authors: David Fluck, Suzanne Rankin, Andrea Lewis, Jonathan Robin, Jacqui Rees, Jo Finch, Yvonne Jones, Gareth Jones, Kevin Kelly, Paul Murray, Michael Wood, Christopher Henry Fry, Thang Sieu Han

Published in: Internal and Emergency Medicine | Issue 3/2022

Login to get access

Abstract

In this study of patients admitted with COVID-19, we examined differences between the two waves in patient characteristics and outcomes. Data were collected from the first COVID-19 admission to the end of study (01/03/2020–31/03/2021). Data were adjusted for age and sex and presented as odds ratios (OR) with 95% confidence intervals (CI). Among 12,471 admissions, 1452 (11.6%) patients were diagnosed with COVID-19. On admission, the mean (± SD) age of patients with other causes was 68.3 years (± 19.8) and those with COVID-19 in wave 1 was 69.4 years (± 18.0) and wave 2 was 66.2 years (± 18.4). Corresponding ages at discharge were 67.5 years (± 19.7), 63.9 years (± 18.0) and 62.4 years (± 18.0). The highest proportion of total admissions was among the oldest group (≥ 80 years) in wave 1 (35.0%). When compared with patients admitted with other causes, those admitted with COVID-19 in wave 1 and in wave 2 were more frequent in the 40–59 year band: 20.8, 24.6 and 30.0%; consisted of more male patients: 47.5, 57.6 and 58.8%; and a high LACE (Length of stay, Acuity of admission, Comorbidity and Emergency department visits) index (score ≥ 10): 39.4, 61.3 and 50.3%. Compared to wave-2 patients, those admitted in wave 1 had greater risk of death in hospital: OR = 1.58 (1.18–2.12) and within 30 days of discharge: OR = 2.91 (1.40–6.04). Survivors of COVID-19 in wave 1 stayed longer in hospital (median = 6.5 days; interquartile range = 2.9–12.0) as compared to survivors from wave 2 (4.5 days; interquartile range = 1.9–8.7). Patient characteristics differed significantly between the two waves of COVID-19 pandemic. There was an improvement in outcomes in wave 2, including shorter length of stay in hospital and reduction of mortality.
Appendix
Available only for authorised users
Literature
2.
go back to reference Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323:1775–1776PubMed Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323:1775–1776PubMed
3.
go back to reference Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM (2020) Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol 92:1759–1760CrossRefPubMed Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM (2020) Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol 92:1759–1760CrossRefPubMed
4.
go back to reference Drefahl S, Wallace M, Mussino E, Aradhya S, Kolk M, Brandén M, Malmberg B, Andersson G (2020) A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun 11:1–7CrossRef Drefahl S, Wallace M, Mussino E, Aradhya S, Kolk M, Brandén M, Malmberg B, Andersson G (2020) A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun 11:1–7CrossRef
5.
go back to reference Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L (2020) Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369:m1985CrossRefPubMedPubMedCentral Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L (2020) Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369:m1985CrossRefPubMedPubMedCentral
7.
go back to reference Fan G, Yang Z, Lin Q, Zhao S, Yang L, He D (2021) Decreased case fatality rate of COVID-19 in the second wave: a study in 53 countries or regions. Transbound Emerg Dis 68:213–215CrossRefPubMed Fan G, Yang Z, Lin Q, Zhao S, Yang L, He D (2021) Decreased case fatality rate of COVID-19 in the second wave: a study in 53 countries or regions. Transbound Emerg Dis 68:213–215CrossRefPubMed
8.
go back to reference Bose S, Adapa S, Aeddula NR, Roy S, Nandikanti D, Vupadhyayula PM, Naramala S, Gayam V, Muppidi V, Konala VM (2020) Medical management of COVID-19: evidence and experience. J Clin Med Res 12:329–343CrossRefPubMedPubMedCentral Bose S, Adapa S, Aeddula NR, Roy S, Nandikanti D, Vupadhyayula PM, Naramala S, Gayam V, Muppidi V, Konala VM (2020) Medical management of COVID-19: evidence and experience. J Clin Med Res 12:329–343CrossRefPubMedPubMedCentral
9.
go back to reference Esposito P, Russo R, Conti N, Falqui V, Massarino F, Moriero E, Peloso G, Traverso GB, Garibotto G, Viazzi F (2020) Management of COVID-19 in hemodialysis patients: the Genoa experience. Hemodial Int 24:423–427CrossRefPubMed Esposito P, Russo R, Conti N, Falqui V, Massarino F, Moriero E, Peloso G, Traverso GB, Garibotto G, Viazzi F (2020) Management of COVID-19 in hemodialysis patients: the Genoa experience. Hemodial Int 24:423–427CrossRefPubMed
10.
go back to reference Poston JT, Patel BK, Davis AM (2020) Management of critically ill adults with COVID-19. JAMA 323:1839–1841PubMed Poston JT, Patel BK, Davis AM (2020) Management of critically ill adults with COVID-19. JAMA 323:1839–1841PubMed
11.
go back to reference Sun Q, Qiu H, Huang M, Yang Y (2020) Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care 10:1–4CrossRef Sun Q, Qiu H, Huang M, Yang Y (2020) Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care 10:1–4CrossRef
12.
go back to reference Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud’homme E, Papazian L (2020) Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA 323:2336–2338CrossRefPubMedPubMedCentral Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud’homme E, Papazian L (2020) Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA 323:2336–2338CrossRefPubMedPubMedCentral
14.
go back to reference Fry CH, Heppleston E, Fluck D, Han TS (2020) Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults. Intern Emerg Med 15:1319–1325CrossRefPubMedPubMedCentral Fry CH, Heppleston E, Fluck D, Han TS (2020) Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults. Intern Emerg Med 15:1319–1325CrossRefPubMedPubMedCentral
15.
go back to reference Heppleston E, Fry CH, Kelly K, Shepherd B, Wright R, Jones G, Robin J, Murray P, Fluck D, Han TS (2021) LACE index predicts age-specific unplanned readmissions and mortality after hospital discharge. Aging Clin Exp Res 33:1041–1048CrossRefPubMed Heppleston E, Fry CH, Kelly K, Shepherd B, Wright R, Jones G, Robin J, Murray P, Fluck D, Han TS (2021) LACE index predicts age-specific unplanned readmissions and mortality after hospital discharge. Aging Clin Exp Res 33:1041–1048CrossRefPubMed
21.
go back to reference World Health Organization (2010) Sex, gender and influenza. World Health Organisation, Geneva World Health Organization (2010) Sex, gender and influenza. World Health Organisation, Geneva
22.
go back to reference Grabowski J, Witkowska N, Bidzan L (2021) Letter to the editor: excess all-cause mortality during second wave of COVID-19–the Polish perspective. Euro Surveill 26:2100117CrossRefPubMedCentral Grabowski J, Witkowska N, Bidzan L (2021) Letter to the editor: excess all-cause mortality during second wave of COVID-19–the Polish perspective. Euro Surveill 26:2100117CrossRefPubMedCentral
23.
go back to reference Heck TG, Frantz RZ, Frizzo MN, François CH, Ludwig MS, Mesenburg MA, Buratti GP, Franz LB, Berlezi EM (2021) Insufficient social distancing may contribute to COVID-19 outbreak: the case of Ijuí city in Brazil. PLoS ONE 16:e0246520CrossRefPubMedPubMedCentral Heck TG, Frantz RZ, Frizzo MN, François CH, Ludwig MS, Mesenburg MA, Buratti GP, Franz LB, Berlezi EM (2021) Insufficient social distancing may contribute to COVID-19 outbreak: the case of Ijuí city in Brazil. PLoS ONE 16:e0246520CrossRefPubMedPubMedCentral
24.
go back to reference Wasdani KP, Prasad A (2020) The impossibility of social distancing among the urban poor: the case of an Indian slum in the times of COVID-19. Local Environ 25:414–418CrossRef Wasdani KP, Prasad A (2020) The impossibility of social distancing among the urban poor: the case of an Indian slum in the times of COVID-19. Local Environ 25:414–418CrossRef
25.
go back to reference Jaja IF, Anyanwu MU, Iwu Jaja CJ (2020) Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa. Emerg Microbes Infect 9:1077–1079CrossRefPubMedPubMedCentral Jaja IF, Anyanwu MU, Iwu Jaja CJ (2020) Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa. Emerg Microbes Infect 9:1077–1079CrossRefPubMedPubMedCentral
27.
go back to reference Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D (2020) Remdesivir for the treatment of COVID-19. N Engl J Med 383:1813–1826CrossRefPubMed Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D (2020) Remdesivir for the treatment of COVID-19. N Engl J Med 383:1813–1826CrossRefPubMed
28.
go back to reference The RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med 384:693–704CrossRef The RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med 384:693–704CrossRef
34.
go back to reference James N, Menzies M, Radchenko P (2021) COVID-19 second wave mortality in Europe and the United States. Chaos 31:031105CrossRefPubMed James N, Menzies M, Radchenko P (2021) COVID-19 second wave mortality in Europe and the United States. Chaos 31:031105CrossRefPubMed
Metadata
Title
Comparison of characteristics and outcomes of patients admitted to hospital with COVID-19 during wave 1 and wave 2 of the current pandemic
Authors
David Fluck
Suzanne Rankin
Andrea Lewis
Jonathan Robin
Jacqui Rees
Jo Finch
Yvonne Jones
Gareth Jones
Kevin Kelly
Paul Murray
Michael Wood
Christopher Henry Fry
Thang Sieu Han
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02842-5

Other articles of this Issue 3/2022

Internal and Emergency Medicine 3/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.